Literature DB >> 1441476

Monoclonal therapy for bacteremia and sepsis.

J Guglielmo, J P Wiener-Kronish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1441476      PMCID： PMC1011246     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  3 in total

1.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

2.  A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.

Authors:  R L Greenman; R M Schein; M A Martin; R P Wenzel; N R MacIntyre; G Emmanuel; H Chmel; R B Kohler; M McCarthy; J Plouffe
Journal:  JAMA       Date:  1991-08-28       Impact factor: 56.272

3.  Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent.

Authors:  K A Schulman; H A Glick; H Rubin; J M Eisenberg
Journal:  JAMA       Date:  1991-12-25       Impact factor: 56.272
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.